Literature DB >> 8687190

Cortical myoclonus in Angelman syndrome.

R Guerrini1, T M De Lorey, P Bonanni, A Moncla, C Dravet, G Suisse, M O Livet, M Bureau, P Malzac, P Genton, P Thomas, F Sartucci, P Simi, J M Serratosa.   

Abstract

Angelman syndrome (AS) results from lack of genetic contribution from maternal chromosome 15q11-13. This region encompasses three GABAA receptor subunit genes (beta3, alpha5, and gamma3). The characteristic phenotype of AS is severe mental retardation, ataxic gait, tremulousness, and jerky movements. We studied the movement disorder in 11 AS patients, aged 3 to 28 years. Two patients had paternal uniparental disomy for chromosome 15, 8 had a >3 Mb deletion, and 1 had a microdeletion involving loci D15S10, D15S113, and GABRB3. All patients exhibited quasicontinuous rhythmic myoclonus mainly involving hands and face, accompanied by rhythmic 5- to 10-Hz electroencephalographic (EEG) activity. Electromyographic bursts lasted 35 +/- 13 msec and had a frequency of 11 +/- 2.4 Hz. Burst-locked EEG averaging in 5 patients, generated a premyoclonus transient preceding the burst by 19 +/- 5 msec. A cortical spread pattern of myoclonic cortical activity was observed. Seven patients also demonstrated myoclonic seizures. No giant somatosensory evoked potentials or C-reflex were observed. The silent period following motor evoked potentials was shortened by 70%, indicating motor cortex hyperexcitability. Treatment with piracetam in 5 patients significantly improved myoclonus. We conclude that spontaneous, rhythmic, fast-bursting cortical myoclonus is a prominent feature of AS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8687190     DOI: 10.1002/ana.410400109

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

Review 1.  Angelman syndrome (AS, MIM 105830).

Authors:  Griet Van Buggenhout; Jean-Pierre Fryns
Journal:  Eur J Hum Genet       Date:  2009-05-20       Impact factor: 4.246

2.  Dystonia in Angelman syndrome: a common, unrecognized clinical finding.

Authors:  Edoardo Ferlazzo; Michele Ascoli; Francesca Abate; Sara Gasparini; Giovanni Mastroianni; Vittoria Cianci; Giulia Ferrigno; Chiara Sueri; Tiziana D'Agostino; Umberto Aguglia
Journal:  J Neurol       Date:  2021-01-23       Impact factor: 4.849

3.  Complex inheritance and parent-of-origin effect in juvenile myoclonic epilepsy.

Authors:  Deb K Pal; Martina Durner; Irene Klotz; Elisa Dicker; Shlomo Shinnar; Stanley Resor; Jeffrey Cohen; Cynthia Harden; Solomon L Moshé; Karen Ballaban-Gill; Edward B Bromfield; David A Greenberg
Journal:  Brain Dev       Date:  2006-01-18       Impact factor: 1.961

4.  Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior.

Authors:  G E Homanics; T M DeLorey; L L Firestone; J J Quinlan; A Handforth; N L Harrison; M D Krasowski; C E Rick; E R Korpi; R Mäkelä; M H Brilliant; N Hagiwara; C Ferguson; K Snyder; R W Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Angelman syndrome resulting from UBE3A mutations in 14 patients from eight families: clinical manifestations and genetic counselling.

Authors:  A Moncla; P Malzac; M O Livet; M A Voelckel; J Mancini; J C Delaroziere; N Philip; J F Mattei
Journal:  J Med Genet       Date:  1999-07       Impact factor: 6.318

6.  Parental view of epilepsy in Angelman syndrome: a questionnaire study.

Authors:  M Ruggieri; M A McShane
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

7.  Angelman syndrome in adulthood.

Authors:  Anna M Larson; Julianna E Shinnick; Elias A Shaaya; Elizabeth A Thiele; Ronald L Thibert
Journal:  Am J Med Genet A       Date:  2014-11-26       Impact factor: 2.802

Review 8.  Valproate as a mainstay of therapy for pediatric epilepsy.

Authors:  Renzo Guerrini
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 9.  Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms.

Authors:  Renzo Guerrini; Romeo Carrozzo; Roberta Rinaldi; Paolo Bonanni
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

10.  Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome.

Authors:  T M DeLorey; A Handforth; S G Anagnostaras; G E Homanics; B A Minassian; A Asatourian; M S Fanselow; A Delgado-Escueta; G D Ellison; R W Olsen
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.